Drugs that contain Cobicistat; Darunavir; Emtricitabine; Tenofovir Alafenamide Fumarate

1. Drug name - SYMTUZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7390791 JANSSEN PRODS Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

US8148374 JANSSEN PRODS Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

US9296769 JANSSEN PRODS Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 JANSSEN PRODS Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100402539C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN101679325A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B JANSSEN PRODS Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN208435B JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B JANSSEN PRODS Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200810487P1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN332719B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2682397B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2487165A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810B1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039718 JANSSEN PRODS Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US10786518 JANSSEN PRODS Compositions and methods of treating HIV Jul, 2038

(15 years from now)

Treatment: Treatment of hiv-1 infection in adult or pediatric patients (>=40 kg) with <50 copies/ml hiv-1 rna after >= 6 months on prior antiretroviral regimen and no known darunavir or tenofovir resistance-associated substitutions

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
150MG;800MG;200MG;EQ 10MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.